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Reproductive potential in women declines with age. Age-related changes in the
ovary account for most of this loss of reproductive function. Oocytes, all of
which are present at birth, decline in number and quality with age. The
endocrine function of the ovary also declines with age, and the ovary becomes
unable to sustain its normal function in the neuroendocrine axis. The neuroen-
docrine axis may be further affected by primary changes occurring in the hypo-
thalamus and pituitary during aging, although this has not been established in
humans. Aging also affects the function ofthe uterus as the endometrium loses
its ability to support implantation and growth ofan embryo. Diminished uterine
function during aging may be due to changes in the uterine vasculature or to
changes in the hormone-dependent development of the endometrium. Finally,
aging increases a woman's risk ofdeveloping medical, gynecologic or obstetric
conditions that may impair her fertility. Knowledge ofthese affects ofaging on
a woman's reproductive function is essential to advise and treat the growing
number ofwomen seeking pregnancy at advanced reproductive age.
INTRODUCTION
Despite the age-related decline in reproductive potential as women age, childbearing
at advanced reproductive age has become increasingly common. In the United States in
1980, 19.8 births per 1000 were to women 35 to 39 years ofage and 3.9 per 1000 were to
those 40 to 44 years ofage [1]. By 1996, these figures had risen to 35.4 and 6.8 per 1000,
respectively. These are the highest birth rates observed for women in their 30s and 40s for
more than two decades [2]. These increased birth rates in older women are attributed to a
trend to delay childbearing due to improved educational and career opportunities as well
as to the increased availability and use ofcontraception [1, 3].
Postponement of pregnancy allows women to achieve educational, career and finan-
cial goals before beginning a family. However, women who seek pregnancy at advanced
reproductive age are more likely to experience difficulty achieving and maintaining a
pregnancy, and delivering a healthy infant compared to their younger counterparts [4-7].
As early as 31 to 35 years of age, spontaneous cumulative pregnancy rates begin to
decline. At 35 to 39 years ofage, one-third ofwomen experience difficulty achieving preg-
nancy andby 40 to 44 years ofage, one-halfofwomen have impaired ability to reproduce
[8]. Spontaneous pregnancy rates approach zero soon after 45 years of age [9]. In donor
insemination programs, cumulative success rates similarly decline with age (Figure 1)
[10]. Less than 55 percent of women over the age of 40 achieve pregnancy within one
year, compared to yearly pregnancy rates of 75 percent in women less than 30 years old
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Figure 1. Theoretical cumulative success rates of donor insemination in women of different
ages with presumed normal fecundity. (Mouzoun et al., 1988 [Ref. 10]. Reproduced with per-
mission).
[I11, 12]. In alarge study specifically investigating the effect ofage onpregnancy rates fol-
lowing in vitro fertilization and embryo transfer (IVF-ET)b and gamete intrafallopian
transfer (GIFT), the pregnancy rate in women 25 to 39 years ofage was 12.2 percent, and
markedly declined to 7.3 percent in women 40 to 43 years ofage, and to only 1.7 percent
in those 44 to45 years ofage [13]. In IVF-ET, GIFT, and otherassistedreproductive tech-
nologies, advanced age generally coffelates with poorer therapy outcomes including a
reduction in oocyte quality, fertilization rate, embryo quality, implantation rate per
embryo and pregnancy rate [13-17] (Figure 1).
Today, at least 20percent ofwomen between 35 and 44 years ofage seekfertility ser-
vices. An understanding ofwhat is currently known about the effects ofage on reproduc-
tive potential is essential to appropriately advise, refer and treat women who seek preg-
nancy at advanced reproductive age. This article will review the major physiological
changes occurring in the aging female reproductive system and will address how these
changes affect female reproductive potential.
AGE AND OOCYTES
Declining oocyte number
Female gametes, oroocytes, areproduced during embryogenesis after whichthey are
gradually depleted during a woman's life. During early embryonic development, approx-
imately 2,000 primordial germ cells migrate to the gonadal ridges. Rapid meiotic multi-
plication then occurs, andby 20 weeks ofgestation, each ovary contains five to seven mil-
lion follicles [18, 19]. Less than 0.1I percent (about400) ofthe oocytes present atbirth will
actually be ovulated during a woman's reproductive life. The remaining oocytes will
degenerate by atresia, a process that begins as early as 15 weeks ofgestation and contin-
ues throughout a woman's life [20]. At approximately 37.5 years of age, when approxi-
mately 25,000 follicles remain, the rate of atresia doubles and results in an increased rate
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Figure 2. Relationship between age and primordial follicle number throughout life. (Based on
data reproduced from Block, 1952 [Ref. 18] and Richardson et al., 1987 [Ref. 21]).
offollicular loss during the perimenopausal period (Figure 2) [18, 21]. By the time ofthe
menopause, which is at approximately 51 years of age, only about 1,000 follicles remain
[22]. This observation has lead some authors to conclude that a follicle count of 1,000 or
less represents a threshold that triggers the cessation of menses. While this mechanism
remains to be confirmed, the established relationship between the number of follicles
remaining and reproductive function could be used to predict the time of a woman's
menopause by counting the number of follicles in her ovaries using sonography. This
approach, however, has not been applied clinically [23, 24]. The increasing rate ofoocyte
loss results in poorer success rates for women of advanced age undergoing IVF-ET
because fewer oocytes are available forretrieval [25]. One study estimated that in women
24 to 32 years of age, the total number of oocytes retrieved declines by 1.25 oocytes per
year [16] (Figure 2).
Although declining oocyte number certainly contributes to lower IVF-ET success
rates in women of advanced reproductive age, a study that controlled for the number of
oocytes retrieved per cycle demonstrated a persistent decline in pregnancy rates with age
[16]. Thus, other factors, in addition to oocyte number, account for the reduced reproduc-
tive success of older women.
Decreasing oocyte quality
Oocyte quality deteriorates and results in impairment of reproductive function in
women of advanced reproductive age [26]. For most of a woman's reproductive life,
oocytes are arrested at a vulnerable stage ofmeiosis. Thus, oocytes are particularly sensi-
tive to the deleterious effects of spontaneous mutations, endogenous hormones and toxic
exposures [5, 27, 28].
The process ofaging does not appear to affect the ability ofolder oocytes to fertilize,
as many studies in the IVF-ET setting have demonstrated similar fertilization rates
between older and younger women. Yet, lower implantation rates and higher spontaneous
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Table 1. Riskofspontaneous abortion related to maternal age. (Warburton et al., 1986 [Ref. 29].
Reproduced with permission.)
Maternal age Spontaneous abortion
(Years) (Percent)
15-19 9.9
20-24 9.5
25-29 10.0
30-34 11.7
35-39 17.7
40-44 33.8
>44 53.2
abortion rates are observed among embryos derived from oocytes obtained from older
women (Table 1) [29-31]. Oocyte age appears to specifically impair embryo implantation
potential, which begins to decline gradually in women at 30 years of age and is reduced
by halfby 40 years of age [15] (Table 1).
The impaired ability ofolder oocytes to achieve the implantation and pregnancy suc-
cess ofyounger oocytes is in part due to a predisposition ofoocytes from older women to
form aneuploid embryos. Aneuploidy, an example of which is trisomy, is a chromosomal
abnormality thatresults from errors in chromosomal segregation during meiosis. The inci-
dence ofaneuploidy is highly correlated with maternal age. Compared to fetuses delivered
by women 24 to 29 years of age, the incidence ofaneuploidy increases by five percent in
fetuses of women 30 to 35 years of age, and increases another five percent in those of
women 36 to 39 years of age [32]. Only fifteen percent of all spontaneous abortions due
to chromosomal trisomy occur in women under 25 years of age, compared to 33 percent
among women 30 to 35 years ofage, and to more than 65 percent for women over40 years
of age [32]. In IVF-ET, aneuploidy correlates with lower rates ofoocyte fertilization and
embryo implantation, poorer embryo development and decreased overall pregnancy
potential [5, 33]. Aneuploidy is a result ofeither nondisjunction ofbivalent chromosomes
or pre-division of sister chromatids at meiosis I [34]. A recent study suggested that
increased maternal age specifically predisposes oocytes to undergo pre-division of sister
chromatids at the first meiotic maturation division [35]. This is supported by the observa-
tion that the meiotic spindle is frequently abnormal in oocytes of older women [36].
Cumulative luteinizing hormone (LH) exposure, which increases with age, may be one
factorresponsible for the age-related increase in aneuploidy [28]. In animal models, when
oocytes are subjected to prolonged exposure to LH in vitro and in vivo by delaying fertil-
ization, high aneuploidy rates and poor survival rates are seen in the resulting embryos
[37, 38]. In humans, a similar process may occur as increasing the interval between ovu-
lation and insemination results in a higher incidence of spontaneous abortion [39].
Alternatively, according to the "production line" hypothesis, fetal aneuploidy may be pre-
determined during the time of oocyte formation, which occurs during late fetal life.
According to this hypothesis, the last oocytes formed have fewerchiasmata and more uni-
valent pairs (which are associated with trisomy) and coincidentally are the last oocytes to
be ovulated during a woman's life [40].
Oocyte degeneration, which is the spontaneous splitting of chromosomes into two
distinct chromatids, also appears to be related to age. Aging oocytes in vitro, though dis-
tinct from biological aging, results in increased rates ofchromosome fragmentation [41].
Cytogenetic analysis ofoocytes that fail to fertilize in patients undergoing IVF-ET and/or
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intracytoplasmic sperm injection (ICSI) reveals a significant increase in chromosome
degeneration in oocytes from older women compared to those obtained from younger
women [31]. Additionally, gene fragmentation and gross abnormalities are more common
in pre-embryos derived from oocytes ofwomen older than 35 years of age [42].
AGE AND THE REPRODUCTIVE NEUROENDOCRINE SYSTEM
The female reproductive neuroendocrine system is composed of the ovarian-hypo-
thalamic-pituitary axis. End organ products secreted by the ovary, including estradiol,
progesterone, and inhibin, function as feedback signals to the hypothalamus and pituitary.
Numerous complex changes occur in the female reproductive system during aging. In nat-
ural reproductive cycles, the ovary requires FSH for normal follicular recruitment and fol-
liculogenesis. During the luteal phase of the previous cycle, the function of the corpus
luteum wanes and estradiol and progesterone levels decline [43]. Decreased estradiol and
progesterone levels allow increased FSH secretion, which stimulates the ovary and results
in the growth and development of a cohort of follicles for the next cycle [44]. As this
cohort of follicles grows and estradiol begins to rise, FSH secretion is gradually sup-
pressed as a result of estradiol positive feedback to the hypothalamic-pituitary system
[44].
Rising gonadotrophin levels and aging
Small increases in follicle stimulating hormone (FSH) secretion are seen in women
as early as their mid-30s at the time ofonset ofthe perimenopausal period [45]. Basal LH
concentrations also rise during the perimenopause, although increases in basal FSH levels
occur up to five years before a rise in LH secretion can be detected (Figure 3) [46-48].
Increased levels of FSH and LH during aging are associated with decreased fertility [45,
49] (Figure 3).
The elevated levels of FSH and LH seen during the perimenopausal period are
believed to reflect waning function of the ovary. The aging ovary loses its ability to
respond to normal FSH levels and to produce appropriate levels of estrogen and proges-
terone to serve as down-regulatory signals to the hypothalamic-pituitary system. It has
been suggested that high FSH levels may be in part responsible for the accelerated deple-
tion ofprimordial follicles seen in the ovary during the perimenopause [21]. High LH lev-
els may cause deleterious effects on the developing oocyte such as accelerated or early
maturation [50]. Increased LH secretion may also cause supraphysiological androgen pro-
duction by the theca cells and follicular atresia [51, 52].
During the perimenopausal period, ovulation continues to occur and cycles are poten-
tially fertile but tend to become less regular. Such changes in the characteristics of a
woman's menstrual cycle may become apparent five to 10 years before she has had her
last menstrual period [21]. As a woman approaches menopause, the frequency of anovu-
latory cycles increases, until ultimately menstruation ceases. The mechanism of
menopause is poorly understood, but numerous factors are believed to affect its onset. For
example, good nutrition [53] and high parity [54] are associated with a later menopause,
whereas smoking and African-American heritage are associated with earlier menopause
[55]. It is interesting to note that despite these life-style, environmental and sociological
effects, the age of menopause has not changed since the middle ages [56].
Gonadotrophin and sex steroid secretion during aging
The relationship between the age-related changes in gonadotropin secretion and the
secretion of sex steroids by the ovary is not clear. Increased secretion of LH and FSH
occurs in cycles in which peri-ovulatory secretion of estradiol and luteal phase secretion
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of progesterone are maintained [49]. Some studies have shown that estradiol levels
increase during the perimenopausal period. Increased estradiol secretion during the peri-
menopausal period can be explained by increased follicular recruitment [57, 58]. In con-
trast, one large study measured daily serum levels ofestradiol and progesterone in healthy
women with normal menstrual cycles and observed no aged-based differences in estradi-
ol and progesterone production at ages ranging from 24 to 50 years [49]. The monotrop-
ic rise in FSH secretion in the presence of normal LH levels is enigmatic since estradiol
levels remain high and since FSH secretion is more sensitive to negative feedback by
estradiol than is LH [59]. Although estradiol is a primary regulator ofFSH secretion [60],
other factors account for the changes in gonadotropin secretion that occur during the per-
imenopause.
Inhibin production and aging
Itis thought thatelevated concentrations ofFSHduring the menopause maybe aresult
ofreduced secretion of inhibin [61]. Inhibin is a glycoprotein molecule secreted by gran-
ulosacells ofthe follicle during the follicularphase ofthe menstrual cycle andby the gran-
ulosa-lutein cells of the corpus luteum during the luteal phase [62, 63]. Although inhibin
selectively suppresses FSH secretion [64], it has been suggested that inhibin also acts as a
trigger for FSH secretion at the end ofthe luteal phase [65] and is, therefore, obligatory for
folliculogenesis. A decreased inhibin level may be used as a marker of waning ovarian
function [66, 67]. Lower follicular phase inhibin levels have been demonstrated in older
women [63] in association with increased FSH levels. Otherdata from assisted conception
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cycles reveal that inhibin levels are significantly reduced in older women during cycles in
which maximum estradiol levels are unchanged [68].
Reproductive aging: in the ovary or the hypothalamic-pituitary axis?
It is generally believed that declining function of the ovary accounts for most, ifnot
all, of the age-related changes in the human reproductive system. The effects of age
observed in the hypothalamus and the pituitary are believed to be secondary. In rodents,
however, primary age-related effects in the hypothalamus and the pituitary have been
demonstrated [69]. When aged rat ovaries are transplanted into younger females, the
ovaries temporarily resume cyclic function under the influence ofa younger hypothalam-
ic-pituitary system [70]. Pituitary sensitivity to estradiol feedback is decreased in aging
rats, probably due to a reduction in the number of estradiol receptors [71]. In addition,
studies ofthe hypothalamus in older rats reveal decreased ability to appropriately release
gonadotrophin releasing hormone [72-74]. However, the applicability ofthe rat as a neu-
roendocrine model forhuman female aging has been questioned since conflicting findings
have been observed in humans. Compelling evidence that age has no direct effect on the
reproductive function of the human hypothalamic-pituitary axis is provided by a study
examining the effects ofaging in oophorectomized women [72]. This study revealed that
in the absence ofovaries, the concentration and pulse pattern ofgonadotropin release do
not differ among women between 27 and 64 years ofage [72]. In contrast, a recent study
demonstrated different patterns of release of hypothalamic and pituitary hormones in
women with idiopathic premature ovarian failure compared to older post-menopausal
women [73]. The central hypothalamic effects of aging may be explained by age-related
slowing ofthe gonadotropin releasing hormone pulse generator [74].
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Figure 4. Clinical pregnancy rate percycle as a function ofboth basal FSH and chronological
age for women 40 and older undergoing ovulation induction. (Pearlstone et al., 1992.
Reproduced with permission).
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Neuroendocrinefunction and reproductive success
The relationships between age-related changes in the ovary, hypothalamus and the
pituitary and the decline of reproductive potential remain to be defined. However, assess-
ment of the neuroendocrine system as a whole is helpful in predicting reproductive suc-
cess. Various methods have been developed to assess neuroendocrine function to estimate
the likelihood of success for women of advanced age undergoing assisted conception.
Currently, the most readily available and minimally invasive method is the determination
of basal FSH levels on day 3 of a woman's menstrual cycle [75]. In women undergoing
IVF, pregnancy rates decrease as FSH levels increase (Figure 4) [76]. Although interpre-
tation of serum levels ofFSH must be institution specific due to assay variation, favorable
or non-favorable prognosis for women undergoing assisted conception may be estimated
by using carefully selected cut-off levels [77]. Some authors have suggested that determi-
nation of basal FSH levels in conjunction with the age of the patient and number of pre-
vious treatment cycles can improve the predictive value of this test [78, 79]. In addition,
increased LH levels, especially in association with increased FSH may predict poor preg-
nancy rates and high rates of spontaneous abortion [80, 81]. Elevated basal estradiol lev-
els or decreased serum inhibin levels may also be used to predict impaired reproductive
function when in the presence of elevated basal FSH levels [82] (Figure 4).
More invasive methods to assess reproductive neuroendocrine function in aging
women have been developed as well. Elevated basal FSH levels in response to challenge
with the anti-estrogen, clomphene citrate, correlate with decreased pregnancy rates.
Although the rate of abnormal tests increases with age, the utility of the clomiphene chal-
lenge test is limited in older women because the age-related decline in reproductive poten-
tial precedes the development of an abnormal test [75]. Another test involves the subcuta-
neous administration ofa gonadotropin releasing hormone agonist. The estradiol response
is then evaluated in conjunction with other parameters such as the age of the patient and
the number of follicles present to estimate reproductive potential. This gonadotrophin-
releasing hormone stimulation test has been implemented in only a single institution and
its general applicability remains to be determined [75].
THE UTERUS AND AGING
Just as many organs suffer the consequences of aging, evidence suggests that age-
related changes occurring within the uterus may affect endometrial receptivity to embryo
implantation and embryo growth and result in reduced fertility. Uterine receptivity is
dependent upon priming of the endometrium by estradiol. This priming involves the pro-
duction of endometrial proteins and glycoproteins such as estrogen and progestin recep-
tors during the follicular phase [83]. Although endometrial morphology appears to be
unaffected by low luteal phase estrogen levels, increased estrogen levels do enhance uter-
ine perfusion through increased vasodilation [84]. Changes in steroid secretion may
increase uterine and endometrial blood flow and, thereby, increase endometrial receptivi-
ty, although no direct evidence for changes in uterine vascular resistance with age has
been demonstrated [85, 86]. In rodents, age-related decline in fertility is attributed in part
to uterine factors [90-92]. Diminished uterine function during aging is supported by find-
ings of age-related decreases in the number of endometrial estrogen and progesterone
receptors [90] and age-related increases in collagen deposition and fibrosis in the rat
endometrium [91]. In humans, no consensus has been reached regarding the effect, ifany,
of age-related diminution in uterine receptivity on reproductive function.
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Lutealphase deficiency anddecreased uterine receptivity
Luteal phase deficiency, by definition, is insufficient progesterone production by the
corpus luteum, which results in inadequate maturation of the endometrium [92].
Progesterone is necessary for implantation and the maintenance of pregnancy [93, 94].
While some data show no difference in ovarian steroid production in women of different
ages [95], other studies have revealed lower luteal-phase progesterone secretion in older
women [73], whichis supportedby the reduced ability ofgranulosa-lutein cells fromolder
women to produce progesterone in vitro [67].
Luteal phase deficiency appears to be associated with abnormal folliculogenesis.
Some data have revealed a reduction in peak follicle diameter in older women with lower
pregnancy rates, reduced luteal phase progesterone secretion and an increased incidence
ofluteal phase deficiency [99-102]. A shortened follicular phase is also associated with a
deficient luteal phase in older women [103-105]. Thus, luteal phase deficiency may con-
tribute to abnormal folliculogenesis with aging and result in higher rates ofinfertility and
recurrent abortion. [103, 104].
Folliculogenesis may be abnormal in patients with luteal phase deficiency due to
increased resistance to blood flow in the intra-ovarian vessels. Increased resistance in
ovarian vessels could result in a relative reduction in blood flow to the corpus luteum
[105]. In monkeys, however, inappropriate gonadotropin secretion causes abnormal fol-
liculogenesis and luteal phase deficiency [106]. Inhumans, some investigators have found
luteal phase deficiency associated with abnormal LH surges [96, 100]. Others have sug-
gested that luteal phase deficiency is associated with alterations in LH pulse frequency
during the follicularphase [107]. LHbinding sites arepresentwithintheendometrium and
it is thought that elevated LH levels, which are seen during the follicular phase and at
advanced age, may have adverse effects on endometrial development [ 108].
The donor oocyte model
Donor oocyte programs provide the optimal setting to study the role of age-related
changes in the uterus on reproductive potential because the confounding variables of
oocyte age and number are removed and the uterine contribution to reproductive potential
may be assessed independently. A report of successful pregnancy and delivery in a 63-
year-old recipient of donated oocytes clearly demonstrates that the uterus can support
pregnancy farbeyond the age at which ovarian competence normally ceases [109]. Studies
from donor oocyte programs reveal similar implantation, pregnancy, miscarriage, and
delivery rates among donor oocyte recipients of different ages and clearly demonstrate
that the aging uterus and endometrium are fully capable of supporting embryo implanta-
tion and ofmaintaining pregnancy. [85, 113-115,]. However, acontribution ofuterine fac-
tors to age-related infertility are not precluded by these findings because the donor oocyte
recipients in these programs were treated with supra-physiological levels ofprogesterone,
which may reverse or overcome the age-related changes in the endometrium. To ade-
quately address this issue, recipients would need to be treated with normal physiological
doses of progesterone [8, 110, 113, 114]. In one study, a higher pregnancy loss rate was
observed in recipients over 40 years of age and correlated with retarded placental secre-
tion of estradiol and progesterone [114].
CONCLUSION
As more and more women delay childbearing until the latter part of their reproduc-
tive lives, understanding the effects ofage on the female reproductive system has become
increasingly important. It is clear that aging impairs a woman's capability to achieve and
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maintain pregnancy, through both natural and assisted methods. Much of this loss in
reproductive potential is accounted for by age-related changes within the ovary. These
changes include a progressive decline in the number ofoocytes available for ovulation or
retrieval, as well as a progressive decline in the capacity of these oocytes to form viable
healthy embryos. In addition, the endocrine function of the ovary is affected by age and
the feedback mechanisms involving FSH, LH and inhibin become significantly altered.
Increased serumFSH signals the onset ofthese changes and is used as a markerofdeclin-
ing reproductive potential. While most age-related changes in the human female repro-
ductive neuro-endocrine system are thought to be secondary to the waning endocrine
function ofthe ovary, some evidence suggests that primary changes occur with age in the
hypothalamus and the pituitary as well. Finally, reproductive potential appears to be
affected by age-related changes in the uterus. Changes in luteal phase hormonal support
of the uterine lining, or changes in blood supply to the uterus may be responsible for the
age-related decline in uterine receptivity. However, through the administration of supra-
physiologic doses of progesterone in donor oocyte programs, these effects of age on the
uterus can be overcome.
The normal physiological aging processes of the ovary, neuroendocrine axis and
uterus result in a general decline in reproductive potential in healthy women as they age.
In addition, age may furtheraffect awoman's reproductive potential by increasing her sus-
ceptibility to pathologic conditions that adversely affect fertility, pregnancy, and fetal out-
come. Fertility is impaired by diseases of the reproductive organs such as endometriosis,
leiomyomas ofthe uterus, infectious tubal peritoneal disease, and cancers ofthe uterus or
ovary, all of which increase in incidence with age [115, 116]. The incidences of gesta-
tional diabetes, preeclampsia, placentaprevia, abnormal labor, Cesarean section and oper-
ative deliveries also increase with age [6]. Additionally, gravidas over the age of 35 are at
a much higher risk for fetal morbidity and mortality than those younger than 30 years of
age [7, 117].
Applying what is known about thephysiological effects ofaging on the female repro-
ductive system will be helpful in the advisement and treatment of women seeking preg-
nancy at an advanced maternal age. However, the specific mechanisms underlying many
of the age-related changes in the ovary, neuroendocrine axis and uterus have not been
established. Further research is necessary to better understand the normal reproductive
physiology of women of advanced reproductive age and to better care for this growing
population.
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